The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Genetic Disease Diagnostic Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Genetic Disease Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Genetic Disease Diagnostic market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Genetic Disease Diagnostic global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Prenatal Diagnosis segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Genetic Disease Diagnostic include Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, and Thermo Fisher Scientific, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Genetic Disease Diagnostic market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Prenatal Diagnosis
Screening for Single Gene Genetic Disease
Preimplantation Genetic Testing
Others
Market segment by Application, can be divided into
Hospital
Medical Laboratory
Others
Market segment by players, this report covers
Abbott
PerkinElmer
Roche Diagnostics
Bio Rad
Thermo Fisher Scientific
BGI Group
Berry Genomics
Da An Gene Co., Ltd.
Illumina
CapitalBio Technology
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Genetic Disease Diagnostic product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Genetic Disease Diagnostic, with revenue, gross margin and global market share of Genetic Disease Diagnostic from 2019 to 2022.
Chapter 3, the Genetic Disease Diagnostic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Genetic Disease Diagnostic market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Genetic Disease Diagnostic research findings and conclusion, appendix and data source.
Geographical Area
Global
The Genetic Disease Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Genetic Disease Diagnostic market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Genetic Disease Diagnostic global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Prenatal Diagnosis segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Genetic Disease Diagnostic include Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, and Thermo Fisher Scientific, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Genetic Disease Diagnostic market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Prenatal Diagnosis
Screening for Single Gene Genetic Disease
Preimplantation Genetic Testing
Others
Market segment by Application, can be divided into
Hospital
Medical Laboratory
Others
Market segment by players, this report covers
Abbott
PerkinElmer
Roche Diagnostics
Bio Rad
Thermo Fisher Scientific
BGI Group
Berry Genomics
Da An Gene Co., Ltd.
Illumina
CapitalBio Technology
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Genetic Disease Diagnostic product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Genetic Disease Diagnostic, with revenue, gross margin and global market share of Genetic Disease Diagnostic from 2019 to 2022.
Chapter 3, the Genetic Disease Diagnostic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Genetic Disease Diagnostic market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Genetic Disease Diagnostic research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Genetic Disease Diagnostic
1.2 Classification of Genetic Disease Diagnostic by Type
1.2.1 Overview: Global Genetic Disease Diagnostic Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Genetic Disease Diagnostic Revenue Market Share by Type in 2021
1.2.3 Prenatal Diagnosis
1.2.4 Screening for Single Gene Genetic Disease
1.2.5 Preimplantation Genetic Testing
1.2.6 Others
1.3 Global Genetic Disease Diagnostic Market by Application
1.3.1 Overview: Global Genetic Disease Diagnostic Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Medical Laboratory
1.3.4 Others
1.4 Global Genetic Disease Diagnostic Market Size & Forecast
1.5 Global Genetic Disease Diagnostic Market Size and Forecast by Region
1.5.1 Global Genetic Disease Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Genetic Disease Diagnostic Market Size by Region, (2017-2022)
1.5.3 North America Genetic Disease Diagnostic Market Size and Prospect (2017-2028)
1.5.4 Europe Genetic Disease Diagnostic Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Genetic Disease Diagnostic Market Size and Prospect (2017-2028)
1.5.6 South America Genetic Disease Diagnostic Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Genetic Disease Diagnostic Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Genetic Disease Diagnostic Market Drivers
1.6.2 Genetic Disease Diagnostic Market Restraints
1.6.3 Genetic Disease Diagnostic Trends Analysis
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Genetic Disease Diagnostic Product and Solutions
2.1.4 Abbott Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Abbott Recent Developments and Future Plans
2.2 PerkinElmer
2.2.1 PerkinElmer Details
2.2.2 PerkinElmer Major Business
2.2.3 PerkinElmer Genetic Disease Diagnostic Product and Solutions
2.2.4 PerkinElmer Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 PerkinElmer Recent Developments and Future Plans
2.3 Roche Diagnostics
2.3.1 Roche Diagnostics Details
2.3.2 Roche Diagnostics Major Business
2.3.3 Roche Diagnostics Genetic Disease Diagnostic Product and Solutions
2.3.4 Roche Diagnostics Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Roche Diagnostics Recent Developments and Future Plans
2.4 Bio Rad
2.4.1 Bio Rad Details
2.4.2 Bio Rad Major Business
2.4.3 Bio Rad Genetic Disease Diagnostic Product and Solutions
2.4.4 Bio Rad Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Bio Rad Recent Developments and Future Plans
2.5 Thermo Fisher Scientific
2.5.1 Thermo Fisher Scientific Details
2.5.2 Thermo Fisher Scientific Major Business
2.5.3 Thermo Fisher Scientific Genetic Disease Diagnostic Product and Solutions
2.5.4 Thermo Fisher Scientific Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.6 BGI Group
2.6.1 BGI Group Details
2.6.2 BGI Group Major Business
2.6.3 BGI Group Genetic Disease Diagnostic Product and Solutions
2.6.4 BGI Group Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 BGI Group Recent Developments and Future Plans
2.7 Berry Genomics
2.7.1 Berry Genomics Details
2.7.2 Berry Genomics Major Business
2.7.3 Berry Genomics Genetic Disease Diagnostic Product and Solutions
2.7.4 Berry Genomics Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Berry Genomics Recent Developments and Future Plans
2.8 Da An Gene Co., Ltd.
2.8.1 Da An Gene Co., Ltd. Details
2.8.2 Da An Gene Co., Ltd. Major Business
2.8.3 Da An Gene Co., Ltd. Genetic Disease Diagnostic Product and Solutions
2.8.4 Da An Gene Co., Ltd. Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Da An Gene Co., Ltd. Recent Developments and Future Plans
2.9 Illumina
2.9.1 Illumina Details
2.9.2 Illumina Major Business
2.9.3 Illumina Genetic Disease Diagnostic Product and Solutions
2.9.4 Illumina Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Illumina Recent Developments and Future Plans
2.10 CapitalBio Technology
2.10.1 CapitalBio Technology Details
2.10.2 CapitalBio Technology Major Business
2.10.3 CapitalBio Technology Genetic Disease Diagnostic Product and Solutions
2.10.4 CapitalBio Technology Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 CapitalBio Technology Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Genetic Disease Diagnostic Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Genetic Disease Diagnostic Players Market Share in 2021
3.2.2 Top 10 Genetic Disease Diagnostic Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Genetic Disease Diagnostic Players Head Office, Products and Services Provided
3.4 Genetic Disease Diagnostic Mergers & Acquisitions
3.5 Genetic Disease Diagnostic New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Genetic Disease Diagnostic Revenue and Market Share by Type (2017-2022)
4.2 Global Genetic Disease Diagnostic Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Genetic Disease Diagnostic Revenue Market Share by Application (2017-2022)
5.2 Global Genetic Disease Diagnostic Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Genetic Disease Diagnostic Revenue by Type (2017-2028)
6.2 North America Genetic Disease Diagnostic Revenue by Application (2017-2028)
6.3 North America Genetic Disease Diagnostic Market Size by Country
6.3.1 North America Genetic Disease Diagnostic Revenue by Country (2017-2028)
6.3.2 United States Genetic Disease Diagnostic Market Size and Forecast (2017-2028)
6.3.3 Canada Genetic Disease Diagnostic Market Size and Forecast (2017-2028)
6.3.4 Mexico Genetic Disease Diagnostic Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Genetic Disease Diagnostic Revenue by Type (2017-2028)
7.2 Europe Genetic Disease Diagnostic Revenue by Application (2017-2028)
7.3 Europe Genetic Disease Diagnostic Market Size by Country
7.3.1 Europe Genetic Disease Diagnostic Revenue by Country (2017-2028)
7.3.2 Germany Genetic Disease Diagnostic Market Size and Forecast (2017-2028)
7.3.3 France Genetic Disease Diagnostic Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Genetic Disease Diagnostic Market Size and Forecast (2017-2028)
7.3.5 Russia Genetic Disease Diagnostic Market Size and Forecast (2017-2028)
7.3.6 Italy Genetic Disease Diagnostic Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Genetic Disease Diagnostic Revenue by Type (2017-2028)
8.2 Asia-Pacific Genetic Disease Diagnostic Revenue by Application (2017-2028)
8.3 Asia-Pacific Genetic Disease Diagnostic Market Size by Region
8.3.1 Asia-Pacific Genetic Disease Diagnostic Revenue by Region (2017-2028)
8.3.2 China Genetic Disease Diagnostic Market Size and Forecast (2017-2028)
8.3.3 Japan Genetic Disease Diagnostic Market Size and Forecast (2017-2028)
8.3.4 South Korea Genetic Disease Diagnostic Market Size and Forecast (2017-2028)
8.3.5 India Genetic Disease Diagnostic Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Genetic Disease Diagnostic Market Size and Forecast (2017-2028)
8.3.7 Australia Genetic Disease Diagnostic Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Genetic Disease Diagnostic Revenue by Type (2017-2028)
9.2 South America Genetic Disease Diagnostic Revenue by Application (2017-2028)
9.3 South America Genetic Disease Diagnostic Market Size by Country
9.3.1 South America Genetic Disease Diagnostic Revenue by Country (2017-2028)
9.3.2 Brazil Genetic Disease Diagnostic Market Size and Forecast (2017-2028)
9.3.3 Argentina Genetic Disease Diagnostic Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Genetic Disease Diagnostic Revenue by Type (2017-2028)
10.2 Middle East & Africa Genetic Disease Diagnostic Revenue by Application (2017-2028)
10.3 Middle East & Africa Genetic Disease Diagnostic Market Size by Country
10.3.1 Middle East & Africa Genetic Disease Diagnostic Revenue by Country (2017-2028)
10.3.2 Turkey Genetic Disease Diagnostic Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Genetic Disease Diagnostic Market Size and Forecast (2017-2028)
10.3.4 UAE Genetic Disease Diagnostic Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Genetic Disease Diagnostic Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Genetic Disease Diagnostic Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Genetic Disease Diagnostic Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Genetic Disease Diagnostic Revenue (USD Million) by Region (2017-2022)
Table 5. Global Genetic Disease Diagnostic Revenue Market Share by Region (2023-2028)
Table 6. Abbott Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Major Business
Table 8. Abbott Genetic Disease Diagnostic Product and Solutions
Table 9. Abbott Genetic Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. PerkinElmer Corporate Information, Head Office, and Major Competitors
Table 11. PerkinElmer Major Business
Table 12. PerkinElmer Genetic Disease Diagnostic Product and Solutions
Table 13. PerkinElmer Genetic Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Roche Diagnostics Corporate Information, Head Office, and Major Competitors
Table 15. Roche Diagnostics Major Business
Table 16. Roche Diagnostics Genetic Disease Diagnostic Product and Solutions
Table 17. Roche Diagnostics Genetic Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Bio Rad Corporate Information, Head Office, and Major Competitors
Table 19. Bio Rad Major Business
Table 20. Bio Rad Genetic Disease Diagnostic Product and Solutions
Table 21. Bio Rad Genetic Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 23. Thermo Fisher Scientific Major Business
Table 24. Thermo Fisher Scientific Genetic Disease Diagnostic Product and Solutions
Table 25. Thermo Fisher Scientific Genetic Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. BGI Group Corporate Information, Head Office, and Major Competitors
Table 27. BGI Group Major Business
Table 28. BGI Group Genetic Disease Diagnostic Product and Solutions
Table 29. BGI Group Genetic Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Berry Genomics Corporate Information, Head Office, and Major Competitors
Table 31. Berry Genomics Major Business
Table 32. Berry Genomics Genetic Disease Diagnostic Product and Solutions
Table 33. Berry Genomics Genetic Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Da An Gene Co., Ltd. Corporate Information, Head Office, and Major Competitors
Table 35. Da An Gene Co., Ltd. Major Business
Table 36. Da An Gene Co., Ltd. Genetic Disease Diagnostic Product and Solutions
Table 37. Da An Gene Co., Ltd. Genetic Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Illumina Corporate Information, Head Office, and Major Competitors
Table 39. Illumina Major Business
Table 40. Illumina Genetic Disease Diagnostic Product and Solutions
Table 41. Illumina Genetic Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. CapitalBio Technology Corporate Information, Head Office, and Major Competitors
Table 43. CapitalBio Technology Major Business
Table 44. CapitalBio Technology Genetic Disease Diagnostic Product and Solutions
Table 45. CapitalBio Technology Genetic Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Genetic Disease Diagnostic Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Genetic Disease Diagnostic Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Genetic Disease Diagnostic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Genetic Disease Diagnostic Players Head Office, Products and Services Provided
Table 50. Genetic Disease Diagnostic Mergers & Acquisitions in the Past Five Years
Table 51. Genetic Disease Diagnostic New Entrants and Expansion Plans
Table 52. Global Genetic Disease Diagnostic Revenue (USD Million) by Type (2017-2022)
Table 53. Global Genetic Disease Diagnostic Revenue Share by Type (2017-2022)
Table 54. Global Genetic Disease Diagnostic Revenue Forecast by Type (2023-2028)
Table 55. Global Genetic Disease Diagnostic Revenue by Application (2017-2022)
Table 56. Global Genetic Disease Diagnostic Revenue Forecast by Application (2023-2028)
Table 57. North America Genetic Disease Diagnostic Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Genetic Disease Diagnostic Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Genetic Disease Diagnostic Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Genetic Disease Diagnostic Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Genetic Disease Diagnostic Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Genetic Disease Diagnostic Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Genetic Disease Diagnostic Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Genetic Disease Diagnostic Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Genetic Disease Diagnostic Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Genetic Disease Diagnostic Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Genetic Disease Diagnostic Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Genetic Disease Diagnostic Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Genetic Disease Diagnostic Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Genetic Disease Diagnostic Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Genetic Disease Diagnostic Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Genetic Disease Diagnostic Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Genetic Disease Diagnostic Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Genetic Disease Diagnostic Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Genetic Disease Diagnostic Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Genetic Disease Diagnostic Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Genetic Disease Diagnostic Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Genetic Disease Diagnostic Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Genetic Disease Diagnostic Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Genetic Disease Diagnostic Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Genetic Disease Diagnostic Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Genetic Disease Diagnostic Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Genetic Disease Diagnostic Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Genetic Disease Diagnostic Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Genetic Disease Diagnostic Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Genetic Disease Diagnostic Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Genetic Disease Diagnostic Picture
Figure 2. Global Genetic Disease Diagnostic Revenue Market Share by Type in 2021
Figure 3. Prenatal Diagnosis
Figure 4. Screening for Single Gene Genetic Disease
Figure 5. Preimplantation Genetic Testing
Figure 6. Others
Figure 7. Genetic Disease Diagnostic Revenue Market Share by Application in 2021
Figure 8. Hospital Picture
Figure 9. Medical Laboratory Picture
Figure 10. Others Picture
Figure 11. Global Genetic Disease Diagnostic Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Genetic Disease Diagnostic Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Genetic Disease Diagnostic Revenue Market Share by Region (2017-2028)
Figure 14. Global Genetic Disease Diagnostic Revenue Market Share by Region in 2021
Figure 15. North America Genetic Disease Diagnostic Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Genetic Disease Diagnostic Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Genetic Disease Diagnostic Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Genetic Disease Diagnostic Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Genetic Disease Diagnostic Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Genetic Disease Diagnostic Market Drivers
Figure 21. Genetic Disease Diagnostic Market Restraints
Figure 22. Genetic Disease Diagnostic Market Trends
Figure 23. Abbott Recent Developments and Future Plans
Figure 24. PerkinElmer Recent Developments and Future Plans
Figure 25. Roche Diagnostics Recent Developments and Future Plans
Figure 26. Bio Rad Recent Developments and Future Plans
Figure 27. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 28. BGI Group Recent Developments and Future Plans
Figure 29. Berry Genomics Recent Developments and Future Plans
Figure 30. Da An Gene Co., Ltd. Recent Developments and Future Plans
Figure 31. Illumina Recent Developments and Future Plans
Figure 32. CapitalBio Technology Recent Developments and Future Plans
Figure 33. Global Genetic Disease Diagnostic Revenue Share by Players in 2021
Figure 34. Genetic Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 35. Global Top 3 Players Genetic Disease Diagnostic Revenue Market Share in 2021
Figure 36. Global Top 10 Players Genetic Disease Diagnostic Revenue Market Share in 2021
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 38. Global Genetic Disease Diagnostic Revenue Share by Type in 2021
Figure 39. Global Genetic Disease Diagnostic Market Share Forecast by Type (2023-2028)
Figure 40. Global Genetic Disease Diagnostic Revenue Share by Application in 2021
Figure 41. Global Genetic Disease Diagnostic Market Share Forecast by Application (2023-2028)
Figure 42. North America Genetic Disease Diagnostic Sales Market Share by Type (2017-2028)
Figure 43. North America Genetic Disease Diagnostic Sales Market Share by Application (2017-2028)
Figure 44. North America Genetic Disease Diagnostic Revenue Market Share by Country (2017-2028)
Figure 45. United States Genetic Disease Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Genetic Disease Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Genetic Disease Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Genetic Disease Diagnostic Sales Market Share by Type (2017-2028)
Figure 49. Europe Genetic Disease Diagnostic Sales Market Share by Application (2017-2028)
Figure 50. Europe Genetic Disease Diagnostic Revenue Market Share by Country (2017-2028)
Figure 51. Germany Genetic Disease Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Genetic Disease Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Genetic Disease Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Genetic Disease Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Genetic Disease Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Genetic Disease Diagnostic Sales Market Share by Type (2017-2028)
Figure 57. Asia-Pacific Genetic Disease Diagnostic Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Genetic Disease Diagnostic Revenue Market Share by Region (2017-2028)
Figure 59. China Genetic Disease Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Genetic Disease Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South Korea Genetic Disease Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Genetic Disease Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Genetic Disease Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Genetic Disease Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Genetic Disease Diagnostic Sales Market Share by Type (2017-2028)
Figure 66. South America Genetic Disease Diagnostic Sales Market Share by Application (2017-2028)
Figure 67. South America Genetic Disease Diagnostic Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Genetic Disease Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Genetic Disease Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East and Africa Genetic Disease Diagnostic Sales Market Share by Type (2017-2028)
Figure 71. Middle East and Africa Genetic Disease Diagnostic Sales Market Share by Application (2017-2028)
Figure 72. Middle East and Africa Genetic Disease Diagnostic Revenue Market Share by Country (2017-2028)
Figure 73. Turkey Genetic Disease Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Genetic Disease Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. UAE Genetic Disease Diagnostic Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
